Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones
作者:I.G. Rathish、Kalim Javed、Shamim Ahmad、Sameena Bano、M.S. Alam、Mymoona Akhter、K.K. Pillai、Syed Ovais、Mohammed Samim
DOI:10.1016/j.ejmech.2012.01.026
日期:2012.3
condensation of appropriate aroylacrylic acid and 4-hydrazinobenzenesulfonamide hydrochloride in ethanol. Five derivatives (2a, 2b, 2d, 2g and 2h) were evaluated for their anticancer activity toward human cancer cell lines by the National Cancer Institute. The 2h showed remarkable activity against SR (leukemia) and NCI-H522 (non-small cell lung) with a GI50 value of less than 0.1 μM. It also displayed
通过适当的芳酰基丙烯酸和4-肼基苯磺酰胺盐酸盐在乙醇中的缩合,合成了一系列带有苯磺酰胺部分(2a - h)的新型哒嗪酮衍生物。美国国家癌症研究所评估了五种衍生物(2a,2b,2d,2g和2h)对人癌细胞的抗癌活性。在2小时显示针对SR(白血病)和NCI-H522(非小细胞肺癌)显着的活性用GI 50值小于0.1μM。它还对白血病(CCRF-CEM,HL-60(TB),K-562,MOLT-4,RPMI-8226),非小细胞肺癌(NCI-H460),结肠(HCT-116, HCT-15,HT29,KMI2,SW-620),中枢神经系统(SF-295),黑素瘤(MALME-3M,M14,MDA-MB-435 SK-MEL-5),卵巢癌(OVCAR-3,NCI / ADR- RES)和GI 50小于1.0μM的乳腺癌(MCF7)癌细胞系。2h的急性毒性研究表明,无胸腺裸鼠对腹膜内(400 mg /